Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
5 items
Photo shows T. Michael Redmond, Ph.D.

NIH vision researcher T. Michael Redmond recognized with Champalimaud Vision Award

September 4, 2018

Vision researcher, T. Michael Redmond, Ph.D., chief of the National Eye Institute (NEI) Laboratory of Retinal Cell and Molecular Biology, is a recipient of the 2018 António Champalimaud Vision Award for foundational science discoveries about the molecular
Photo shows microscopy image of exosomes in green surrounding rentinal ganglion cells in yellow and orange.

Stem cell secretions may protect against glaucoma

January 26, 2017

A new study in rats shows that stem cell secretions, called exosomes, appear to protect cells in the retina, the light-sensitive tissue in the back of the eye.
NEI logo.

Phase 1 Clinical Trial Results of Gene Transfer for Leber Congenital Amaurosis Reported

September 8, 2008

Three young adults with Leber Congenital Amaurosis-a severe degenerative disease of the retina caused by a mutation in the RPE65 gene-reported improvements in vision after undergoing a specialized gene transfer procedure.
NEI logo.

Statement on Clinical Trial of Gene Transfer Therapy for Childhood-Onset Blindness

November 1, 2007

The National Eye Institute (NEI) of the National Institutes of Health (NIH) is supporting a phase I clinical trial to assess the safety of gene transfer in treating people with a form of Leber congenital amaurosis (LCA).
NEI logo.

Defective Mouse Gene Linked to Childhood Blindness

November 30, 1998

For centuries, children have been reciting the Mother Goose nursery rhyme, “Three Blind Mice.” Now, researchers studying a new strain of blind mice may know what caused their blindness and, more importantly, how this knowledge might someday prevent some..